| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9e4cedb72851f01dadac14d585e8b17 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2018-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3b846907cdf9ad39ce8c614d70e60bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5ab29514ae4c39d89db746673d3875a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34596c400d7ac111d984339186b376e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6003a842d5936c7416e5153d0490e541 |
| publicationDate |
2018-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2018201013-A1 |
| titleOfInvention |
Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride |
| abstract |
Novel crystalline forms of 3-(imidazo[1,2-blpyridazin-3-ylethyny)-4-methyl-N-{4-[(4 methylpiperazin- 1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride and to methods of their preparation are disclosed herein. |
| priorityDate |
2012-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |